Skip to main content
. 2016 Feb 12;10(2):e0004462. doi: 10.1371/journal.pntd.0004462

Table 2. Prevalence of trachoma, infection and antibodies against C. trachomatis protein antigens in examination, high-prevalence and serology arms.

Community means with 95% CIs.

Examination High-Prevalence Serology
Trachomaa 0.3% (0.1 to 0.8%) 1.0% (0.4 to 2.0%) 0% (0 to 5.3%)
C. trachomatisb 0% (0 to 0.3%) 0% (0 to 0.5%) 0% (0 to 0.5%)
pgp3c 1.5% (0.04 to 7.9%)
CT694c 0% (0 to 5.3%)

aTF and/or TI using WHO system.

bAmplicor PCR

cC. trachomatis protein antigens.